Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genetic and epigenetic determinants of clopidogrel response in acute coronary syndromes
ChiCTR-OPN-15006260Phase 4Recruiting
- Sponsor
- Pharmacogenetics Research Institute, Xiangya Hospital, Central South University
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of clopidogrel in acute coronary syndrome (ACS), sponsored by Pharmacogenetics Research Institute, Xiangya Hospital, Central South University. Started May 2015; status: recruiting.
02
Drugs
clopidogrel
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on ChiCTR-OPN-15006260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-15006260.